CDC advisers recommend resuming use of the J&J Covid vaccine, saying the benefits outweigh the risks of rare clots. Now, the FDA and CDC will review.
Vaccine advisers to the US Centers for Disease Control and Prevention voted Friday to recommend resuming use of the Johnson & Johnson coronavirus vaccine.
An updated warning will be added to the label.
Members of the CDC's Advisory Committee for Immunization Practices agreed the benefits of the vaccine outweigh the risks from rare blood clots linked with the vaccine. | | | | | | | | |
